News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Pfizer Inc.'s Wyeth Defeats Australian Generic Challenge Against Antidepressant Effexor Patent
November 9, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Wyeth, a unit of Pfizer Inc., beat back a challenge from generic drug makers against the patent on the extended-release form of its antidepressant Effexor in Australia.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Asia
Australia
Pfizer
MORE ON THIS TOPIC
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
·
2 min read
·
Tristan Manalac
HIV
Gilead Partners With US State Department to Distribute Yeztugo to Low-Income Countries
September 5, 2025
·
1 min read
·
Tristan Manalac
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
·
4 min read
·
Annalee Armstrong
CDC
ACIP Revamp Continues as Kennedy Eyes Seven New CDC Vaccine Advisors
September 4, 2025
·
2 min read
·
Dan Samorodnitsky